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ABSTRACT 
The leucine-rich glioma inactivated (LGI) gene subfamily contains four highly conserved 
members (LGI1, 2, 3 and 4), which have been described in human, mouse and other mammalians. 
Although their main roles remain unknown, LGI1 gene mutations have been found in human partial 
temporal lobe epilepsy. Moreover, previous studies showed that the products of these genes exert 
their function in the nervous system. The anatomical distribution of these gene transcripts in the 
brain might give some insight to elucidate their possible function. In this study, the pattern of 
expression of the four LGI genes was assessed in the brain of C57BL/6J adult mice by in situ 
hybridization. We found that the LGI1 transcript is mainly expressed in the dentate gyrus and CA3 
field of the hippocampus. LGI2 and LGI4 genes, which showed a similar pattern of distribution with 
minor differences, were mostly expressed in the medial septal area, thalamic reticular nucleus and 
substantia nigra pars compacta. LGI3-expressing cells were distributed widespread, but were 
more consistently observed in the hippocampal formation, thalamic and hypothalamic nuclei, 
substantia nigra and reticular formation.  
In summary, LGI1 gene expression is very restricted to intrahippocampal circuitry, which might 
be related to its involvement in temporal lobe epilepsy. The patterns of expression of LGI2 and 
LGI4 genes are very similar and their distribution in the vertical limb of the diagonal band and in 
putative hippocampal interneurons, suggest that the function of these genes might be related to 
the generation of hippocampal theta rhythm. Finally, LGI3 gene widespread expression in the 
brain suggests that its transcripts might be involved in a common cellular process present in 
different neuronal types. 
Section: Cellular and Molecular Biology of Nervous Systems. 
Keywords: LGI1; LGI2; LGI3; LGI4; C57BL/6J mice; In situ hybridization. 
Abbreviations: ac, anterior commissure; Acb, accumbens nucleus; aci, anterior commissure, 
intrabulbar part; ACo, anterior cortical amygdaloid nucleus; AD, anterodorsal thalamic nucleus; 
AHA, anterior hypothalamic area; AOB, accesory olfactory bulb; AOD, anterior olfactory bulb, 
dorsal part; AOE, anterior olfactory bulb, external part; AOL, anterior olfactory bulb, lateral part; 
BA, basal amygdala; BLA, basolateral anterior amygdala; BMA, basomedial amygdaloid nucleus, 
anterior part; BST, bed nucleus of the stria terminalis; CA1, Ammon's horn 1; CA2, Ammon's horn 
2; CA3, Ammon's horn 3; Ce, cerebellum; CeA, central amygdala; CIC, central nucleus of the 
inferior colliculus; CM, centromedial thalamic nucleus; CPu, caudate putamen; DC, dorsal cochlear 
nucleus; DCIC, dorsal cortex of the inferior colliculus; DD, deep dorsal nucleus; DeCe, dentate 
nucleus of the cerebellum; DeN, dentate nucleus; DEnd, dorsal endopiriform; DG, dentate gyrus; 
DGSC, deep gray layer of superior colliculus; Dk, Darkschewitsch nucleus; DpMe, deep 
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mesencephalic nucleus; DR, dorsal raphe nucleus; DSub, dorsal subiculum; ec, external 
capsula; Ent, entorhinal cortex; EPL, external plexiform layer of the olfactory bulb; f, fornix; FC, 
fasciola cinereum; Gl, glomerular layer of the olfactory bulb; GrL, cerebellar granular layer; GrO, 
granular cell layer of the olfactory bulb; Hb, habenula; ic, inner capsula; icp, inferior cerebellar 
peduncle; IF, interfascicular nucleus; IGSC, inner gray layer of the superior colliculus; IO, inferior 
olive; IP, interpeduncular nucleus; IPl, internal plexiform layer of the olfactory bulb; La, lateral 
amygdala; LD, laterodorsal thalamic nucleus; LG, lateral geniculate nuclei; LH, lateral 
hypothalamic area; lHb, lateral habenula; LL, lateral lemniscus; LM, lateral mammillary nucleus; 
LP, lateral posterior thalamic nucleus; LPO, lateral preoptic area; LSd, lateral septal nucleus, 
dorsal part; LSi, lateral septal nucleus, intermediate part; LVe, lateral vestibular nucleus, dorsal 
part; MdR, medullary reticular nucleus; MeA, medial amygdala; mfb, medial forebrain bundle; MG, 
medial geniculate body; MGd, dorsal division of the medial geniculate body; MGv, ventral division 
of the medial geniculate body; mHb, medial habenula; Mi, mitral cell layer of the olfactory bulb; ML, 
lateral division of the medial mammillary nucleus; MM, medial division of the medial mammillary; 
MMn, median division of the medial mammillary nucleus; MnR, median raphe nucleus; MOB, main 
olfactory bulb; MoV, motor nucleus of the trigeminal nerve; MPO, medial preoptic area; MS, medial 
septal nucleus; MS/LS, transition area between medial and lateral septum; mta, mammillothalamic 
tract; mtg, mamillotegmental tract; NTS, nucleus of the solitary tract; Pa, pallidal nucleus; PAG, 
periaqueductal gray; PaV, paraventricular hypothalamic nucleus; pcvLGN, parvocellular division of 
the lateral geniculate nucleus; PIN, posterior intralaminar cortex; Pir, piriform cortex; Pn, pontine 
nuclei; PrV, principal nucleus of the trigeminus nerve; PTA, pretectal area; Pu, putamen; PVP, 
paraventricular thalamic nucleus, posterior division; pyx, pyramidal decussation; Re, reuniens 
thalamic nucleus; RF, reticular formation; RLi, rostral linear nucleus of the raphe; RN, red nucleus; 
RPC, red nucleus, parvicellular part; RPO, reticularis pontis oralis; Rt, reticular thalamic nucleus; 
SC, superior colliculus; SI, substantia innominata; sm, stria medullaris of the thalamus; SNc, 
substantia nigra, pars compacta; SNr, substantia nigra, pars reticulata; SpV, spinal trigeminal tract; 
st, stria terminalis; SuM, supramammillary nucleus; TT, taenia tecta; TS, triangular septal nucleus; 
VCA, ventral cochlear nucleus, anterior part; VCP, ventral cochlear nucleus, posterior part; vDB, 
nucleus of the vertical limb of the diagonal band; VL, ventrolateral thalamic nucleus; VP, ventral 
pallidum; VPL, ventral posterolateral thalamic nucleus; VPo, ventral posterior thalamic nucleus; 
VTA, ventral tegmental area; ZI, zona incerta.
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1. INTRODUCTION 
The leucine-rich glioma inactivated (LGI/Epitempin) gene subfamily belongs to the large 
leucine-rich repeat protein family. Searching for homology sequences in public databases, based 
on the previously known LGI1 protein sequence, revealed the existence of a highly homologous 
group of proteins that contain the so-called EPTP repeats (Pfam PF03736): LGI1, LGI2, LGI3, 
LGI4, VLGR1 and TNEP1 {Staub, 2002 #4522}. The EPTP repeats were first identified in the LGI1 
sequence and are thought to generate a beta-propeller structure, a potential protein-protein 
interaction domain {Kobe, 2001 #4388}. Moreover, the four LGI proteins also contain cysteine-
flanked leucine-rich repeats, which confer them a highly similar domain structure {Staub, 2002 
#4522}. Another common feature of this group of proteins is that overexpression in several cell 
lines of either LGI shows that the products of these genes are glycosylated secreted proteins 
{Senechal, 2005 #5017}. In addition, defective LGI1 gene gives rise to a mutant protein that is 
neither secreted nor unstable {Senechal, 2005 #5017}. 
Information about the LGI1 gene and protein is more abundant than for the rest of the family 
members. LGI1 gene was discovered in the T98G glioblastoma cell line, where it was rearranged 
as a result of a t(10;19)(q24;q13) balanced translocation {Chernova, 1998 #3080}. Thus, it was 
proposed to be a tumor suppressor gene based on its lower expression in human glial tumor and 
glioblastoma cell lines when compared to normal brain samples {Chernova, 1998 #3080}. Further 
investigation led to the discovery that LGI1 gene mutations caused autosomal dominant lateral 
temporal epilepsy (ADLTE) {Kalachikov, 2002 #4318;Morante-Redolat, 2002 #4526;Gu, 2002 
#4527}. Analysis of LGI1 gene expression revealed that it is strongly transcribed in neurons, but 
not in glial cells {Kalachikov, 2002 #4318;Senechal, 2005 #5017}; nevertheless, LGI1 gene is also 
expressed in other tissues {Head, 2007 #5037}. It has been hypothesized that LGI1 might be 
involved in cell motility and invasiveness {Kunapuli, 2003 #4625;Kunapuli, 2004 #4936}. 
Furthermore, {Schulte, 2006 #5039} have reported that the LGI1 protein binds to the presynaptic 
voltage-gated K+ channel (Kv) where, as part of the Kv complex, prevents the N-type inactivation 
mediated by the Kvß1 subunit. Mutant LGI1 proteins may fail in inactivating Kvß1, which would 
result in channels closing faster. Thus, slowly repolarized terminals of LGI1 defective neurons may 
induce focal seizures {Schulte, 2006 #5039}. Additional information on putative LGI1 function 
arises from the observation that LGI1 oligomers interact with post-synaptic ADAM22 receptors 
{Fukata, 2006 #5040}, which suggests that secreted LGI1 protein enhances AMPA receptor-
mediated excitatory transmission {Fukata, 2006 #5040}. But the most relevant proof about the 
function of LGI1 lie on the discovery by Zhou and co-workers, that this protein mediates postnatal 
structural pruning and functional maturation of glutamatergic synapses in hippocampus, while 
mutant LGI1 prevents this process in transgenic mice. Moreover, they suggest that LGI1 acts at 
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the presynaptic terminus to reduce Kv1-mediated inhibition over the Kv1.1 channel {Zhou, 2009 
#5614}. 
Conversely, there is scarce data on the function of LGI3 and LGI4 and no data about LGI2. 
Several studies have shown that the beta amyloid peptide (Abeta) upregulates and colocalizes 
with LGI3 protein in the cell membrane and with internalized Abeta in astrocytes {Kimura, 2007 
#5533;Okabayashi, 2008 #5531;Okabayashi, 2007 #5532}. Western blot analyses demonstrated 
that both glial fibrillary acidic protein (GFAP) and apolipoprotein E (ApoE) significantly increased 
with simultaneous Abeta-induced upregulation of LGI3, suggesting that activated LGI3 protein may 
be involved in the astroglial response against Abeta {Kimura, 2007 #5533}. Furthermore, it has 
been reported that LGI3 colocalizes with Abeta in cultured rat astrocytes, whereas RNA 
interference experiments demonstrate that LGI3 downregulation clearly inhibites Abeta uptake by 
cultured astrocytes {Okabayashi, 2008 #5531}. These results strongly suggest that the LGI3 
protein is involved in Abeta uptake by astrocytes {Okabayashi, 2008 #5531}. With respect to 
neurons, in brains from aged monkeys, LGI3 protein accumulates on or near neuronal plasma 
membranes, where it colocalizes with endocytosis-associated proteins and lipid raft markers 
{Okabayashi, 2007 #5532}. On the other hand, syntaxin-1, a SNARE component in exocytosis, 
has been identified as an LGI3-associated protein by pull-down, coimmunoprecipitation and 
colocalization techniques {Park, 2008 #5446}. The results obtained from these studies suggest 
that LGI3 protein may play a regulatory role in neuronal endocytosis {Okabayashi, 2007 #5532} 
and exocytosis via interaction with syntaxin 1 {Park, 2008 #5446}. 
With regard to LGI4, its ablation is associated with a defective Schwann cell signalling pathway, 
resulting in abnormal peripheral nerve development that causes the claw paw mutation in mice 
{Bermingham, 2006 #5032}. Results from immunoprecipitation and mass spectrometric analysis 
from mice brain proteins also link LGI4 and LGI1 to ADAM22, revealing that either LGI1 or LGI4 
can bind to ADAM22, ADAM11 and ADAM23 with different affinity. In fact, it appears that ADAM23 
works as an LGI1 receptor in the ADAM22-negative cells and therefore, these systems could be 
regulated not only by affinity, but also by the cell-type-specific expression of each protein {Sagane, 
2008 #5510}. 
Data regarding on the distribution pattern of neurons expressing the different types of LGI 
proteins are scarce. The expression of these genes in human brain has been assessed by semi-
quantitative PCR {Gu, 2002 #4347}, but little is known about their expression in other tissues. In 
mouse brain, {Kalachikov, 2002 #4318} described the regional distribution of LGI1 expressing 
neurons in the hippocampus and cortex. In addition, {Senechal, 2005 #5017} reported the 
comparative distribution of LGI1-4 expressing neurons; however, the reported maps only 
contained one sagital section for each gene. Finally, {Lee, 2006 #5600} showed that LGI3 
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transcripts are widespread expressed in the mouse brain, but the authors did not analyze the 
expression pattern of this gene in detail. Thus, the aim of the present study is to describe the 
detailed neuroanatomic distribution of the transcripts of the four LGI genes (LGI1-4) in the mouse 
brain using in situ hybridization (ISH). An accurate map of the regional distribution of these 
transcripts in the brain might provide some insight about the putative function/s of each LGI gene. 
Thus, a stronger expression of one of these genes in a distinct brain region most likely will point 
out towards a particular function of the encoded protein in that specific neuronal group. 
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2. RESULTS 
In the present study, we used in situ hybridization to determine the anatomical distribution of 
cells expressing transcripts of the LGI gene family, LGI1, 2, 3 and 4, in the mouse brain. Two 
sense and two antisense digoxigenin-labeled probes were designed and synthesized for each of 
the genes mentioned above. The pattern of expression of each LGI gene is summarized in 
Figure 1 and Table 2. To demonstrate the specificity of the binding of the designed probes to the 
different LGI transcripts, brain sections were processed using sense probes instead of antisense. 
We verified that the complementary sense probe for each antisense probe did not show signal 
(this is illustrated in Figure 2A for LGI1 transcripts in the hippocampus). Each pair of antisense 
probes showed an equal labeling pattern for their corresponding gene transcript. No regional or 
intensity differences were observed in the labeling within each pair of probes. 
 
LGI1 gene expression 
The majority of LGI1 expressing cells were located in anatomically defined areas. The entire 
brain, including the olfactory bulb, and the cervical spinal cord were analyzed, although we only 
found LGI1-labeled cells in the telencephalon (Figure 1, A1-S1). 
The strongest LGI1 expression signal was observed in the dentate gyrus and in the CA3 and 
CA2 fields of the hippocampal formation (Figure 2B). Labeling in the CA1 field was weak but 
evident. There was also some strong signal in the subicular area (Figure 2C). LGI1 expression in 
the hippocampal formation was restricted to the pyramidal and granular layers, whereas scattered 
labeling was observed outside these areas (Figure 2C).  
Labeling in the cerebral cortex was weak but evident. No regional area showed a higher 
labeling than others. In contrast, within each area inner layers (V-VI) showed a stronger labeling 
than outer (I-IV) ones, which showed almost no signal. There were clusters of labeled perikarya in 
both medial and lateral entorhinal cortices, which we have identified as layers II and III 
(Figure 2D). Some labeling was also present in the piriform cortex. LGI1-labeled cells were also 
scarce and dispersed in the amygdala, mainly in the basolateral complex. The central and medial 
amygdala, along with the cortical amygdala, contained few or no labeled cells (Figure 2E). The 
lateral septum contained labeled perikarya specifically in the caudal dorsal nucleus. Some 
scattered labeled cells were also observed in the caudate putamen area (Figure 2F). LGI1-labeled 
cells were absent in the olfactory bulb, diencephalon, brainstem and spinal cord. 
 
LGI2 gene expression 
A consistent pattern of LGI2 transcription was observed throughout the entire brain 
(Figure 1 B2-S2). The LGI2 gene was expressed in scattered cells of all layers of the main 
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olfactory bulb (Figure 3A). There were also labeled cells in the accessory olfactory bulb, and a 
strong signal was observed in the external division of the anterior olfactory nuclei (Figure 3B). 
Within the cerebral cortex, labeling was present in all cortical areas with no apparent regional 
differences. In contrast, for each area cells were intensely labeled (although in a diffuse way) in 
the inner layers (V-VI) whereas no labeling was found in the outer layers (I-IV) (Figure 3C). Some 
labeled cells were observed in layers II and III of the piriform cortex (Figure 3D). 
In the hippocampal formation, LGI2 expressing cells were dispersed in all layers of both the 
dentate gyrus and Ammon’s horn. Interestingly, both pyramidal and granular layers were 
unlabeled (Figure 3E). This observation, together with the scattered distribution of the labeled cells 
and the absence of cellular labeling in olfactory bulbs or spinal cord among other areas, strongly 
suggests that the LGI2 expressing cells in the hippocampus are interneurons. In addition, dense 
labeling was observed in the deep layers of the subiculum. 
Expression of LGI2 in the amygdalar complex was diffuse (Figure 3F), whereas strong labeling 
was found specifically in the supracapsular part of the bed nucleus of the stria terminalis. 
Within the septal area, strong labeling was present in the vertical limb of the diagonal band-
medial septum, specifically in the most medial area. Conversely, the horizontal limb and lateral 
areas of the medial septum-diagonal band complex were unlabeled (Figure 3G). Only some 
clusters of LGI2-labeled cells were observed lateral to the medial septum in the medial 
septal/lateral septal transition zone. 
The expression pattern of LGI2 in the basal ganglia showed a specific distribution: labeled cells 
were dispersed in the caudate putamen area, whereas strong and concentrated labeling was 
found in the pallidum. 
A consistent pattern of labeling was obtained in the thalamus. No labeling was observed in the 
most dorsal thalamic nuclei, with the exception of the anterodorsal thalamic nucleus. The strongest 
labeling was observed at all levels of the reticular nucleus (Figure 3E). Clusters of labeled cells 
were found in the magnocellular ventral division of the lateral geniculate nucleus. Dense labeling 
also occurred in the deep dorsal nucleus of the posterior intralaminar complex, between the dorsal 
and ventral divisions of the medial geniculate body. Labeled cells also appeared in the medial 
division of the lateral habenular nucleus. In addition, some labeling was also present in both 
divisions of the zona incerta (Figure 4A). 
Some weak but consistent labeling was noted in both the medial preoptic nucleus and in the 
lateral preoptic area. The medial division of the medial mammillary nucleus showed a robust LGI2 
transcription signal (Figure 4B). Faint or no expression was observed in the rest of the 
hypothalamic nuclei. 
At the mesencephalic level, strong labeling was observed in both the pars reticulata and the 
pars compacta of the substantia nigra, and also in the ventral tegmental area. In addition, LGI2 
expression was also observed in the interpeduncular nuclei. Scattered labeled cells were observed 
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in several areas of the brainstem such as the deep mesencephalic reticular formation, red 
nucleus, interstitial nucleus of Cajal, and deep gray layer of the superior colliculus. Some labeling 
occurred in the pericentral nuclei of the inferior colliculus and also in the intercollicular nucleus. 
At the pontine and medullary levels, some LGI2 expression was present in the median and 
dorsal raphe nuclei. Scattered labeled cells were found in the reticular formation. Some LGI2 
signal was present in the granular layer of the dorsal cochlear nucleus; whereas some dispersed 
labeled cells were located in the ventral anterior and ventral posterior cochlear nuclei. This same 
pattern of diffuse labeling was observed in the vestibular nuclei and in the principal and spinal 
trigeminal nuclei. In contrast, strong LGI2 labeling was observed in the inferior olive (Figure 4C).  
In the cerebellum, high expression LGI2 levels were observed in a fraction of cells of the 
granular layer of the cerebellar cortex. Some weak but consistent labeling was also observed in 
the deep cerebellar nuclei (Figure 4D). LGI2 labeling was not found in any division of the spinal 
cord. 
 
LGI3 gene expression 
In contrast to the rest of the LGI genes, LGI3 was expressed more diffusely in the 
diencephalon, and presented a restricted labeling pattern in the rest of the brain (Figure 1 A3-S3). 
Labeled cells were scarce in the granular layer of the main and the accessory olfactory bulb, and 
some labeling was found in the mitral cell layer of the main olfactory bulb. 
The neocortex showed diffuse LGI3 labeling with no apparent regional differences. Strong 
labeling was found in both the granular layer of the dentate gyrus and the pyramidal layer of the 
Ammon’s horn (Figure 5A). In addition, some sparse LGI3 labeling was present in different layers 
of the hippocampal formation. The lateral and central nuclei of the amygdala showed strong LGI3 
labeling (Figure 5B), as well as the pallidum and some cells in the caudate-putamen area. Many 
disperse LGI3 labeled cells were found mainly in the dorsal thalamus, although all the thalamic 
area was labeled (Figure 5C). Although the LGI3 signal was present in nearly all nuclei of the 
thalamus including the medial habenular nucleus (Figure 5D), the intensity of the signal was weak. 
In the subthalamus, some faint mRNA expression was detected in the zona incerta and the medial 
and lateral nuclei. Weak LGI3 signal was observed in the supraoptic, paraventricular, ventromedial 
and mammillary nuclei of the hypothalamus. No LGI3 labeling was observed in both the superior 
and inferior colliculi, contrasting with the strong labeling found in the periaqueductal gray. The 
oculomotor nuclei showed lower levels of labeling. Some LGI3 labeling was observed in the 
substantia nigra pars compacta, which was higher than in the pars reticulata (Figure 5E). No LGI3 
labeling was detected in the interpeduncular and interfascicular nuclei, but some labeling was 
present in the ventral tegmental area. 
Along the reticular formation, strong LGI3 labeling was observed associated with large cells 
located in the mesencephalic reticular formation, the reticularis pontis oralis and caudalis, and the 
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medial magnocellular division of the medullary reticular formation. In the cerebellum some 
labeled cells were observed in the deep cerebellar nuclei and in the Purkinje cell layer. No labeling 
was observed in the spinal cord. 
 
LGI4 gene expression 
The pattern of expression of the LGI4 gene was very similar to that observed for the LGI2 gene 
expression, and corresponded to well defined anatomical areas (Figure 1 A4-S4). 
LGI4 labeling in the olfactory bulb was similar to that described for LGI2 transcripts. Some 
labeling was found in the granular layer of the main olfactory bulb and in the accessory olfactory 
bulb. 
The LGI4 expression in the cerebral cortex was very similar to LGI1 and LGI2 distribution, 
where scattered cells showed strong LGI4 labeling in the deep layers (V-VI), whereas the 
superficial layers (I-IV) remained unlabeled (Figure 6A).  
Some labeling occurred in the layer II of the piriform cortex and in the endopirifom nucleus. 
LGI4 labeling in the hippocampal formation was slightly different to that observed for LGI2. Weak 
LGI4 labeling was observed in the pyramidal and granular layers of the hipoccampal formation, 
whereas scattered putative interneurons showed strong labeling (Figure 6B). Weak LGI4 labeling 
was also observed in the amygdala, although a group of labeled perikaria was seen in the medial 
lateral division of the central nucleus. A stronger LGI4 signal was observed in the supracapsular 
bed nucleus of the stria terminalis. 
LGI4 labeling in the medial septum was identical to that observed for LGI2 transcripts, being 
restricted to the vertical limb of the diagonal band and its most medial subdivision. This labeling 
was the strongest LGI4 signal observed in the brain (Figure 6C). In addition, some LGI4 labeled 
cells were concentrated in the lateral septum/medial septum transition zone. 
Faint LGI4 labeling was observed in the caudate-putamen whereas, like in the LGI2 pattern, 
strong labeling was found in the lateral globus pallidus (Figures 6D and E).  
As with LGI2 transcripts, the strongest LGI4 signal in the thalamus was observed in the nucleus 
reticularis (Figure 6E). Some labeled cells were also found in the zona incerta and in the lateral 
nucleus of the habenula. In addition, some LGI4 labeling was specifically observed in the deep 
dorsal nucleus of the posterior intralaminar complex (Figure 6F). 
In the mesencephalon, some LGI4 labeled cells were observed in the deep mesencephalic 
reticular formation, anterior pretectal nuclei, nucleus of Darkschewitch and nucleus of the posterior 
commissure. Strong LGI4 labeling was also found in both the pars reticulata and the pars 
compacta of the substantia nigra (Figure 7A), the ventral tegmental area, and the rostral dorsal 
interpeduncular nucleus (Figure 7B and C). Some labeling was detected in the pericentral nuclei of 
the inferior colliculus, and an intense LGI4 signal was observed in some dispersed cells of the 
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intercollicular area. No LGI4 labeling was observed in the superior colliculus and in the 
periaqueductal gray. 
In the pons, medulla and cerebellum LGI4 labeling was nearly identical to that observed for 
LGI2. Some diffuse signal was observed in the median and dorsal raphe nuclei and the reticular 
formation. LGI4 expression was also present in the cochlear vestibular and trigeminal nuclei, 
whereas strong labeling was observed in the inferior olive. In the cerebellum, strong LGI4 signal 
was present in some cells of the granular layer of the cerebellar cortex, whereas some weak 
labeling was seen in the deep cerebellar nuclei. LGI4 labeling was not detected in the spinal cord. 
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3. DISCUSSION 
With this procedure, we have generated a detailed map of the pattern of expression of each 
LGI gene within defined anatomical divisions in the brain. Based on the regional distribution of the 
transcripts for each gene, we have speculated about their possible involvement in a particular 
function. 
We have used two antisense digoxigenin-labeled probes for each gene. Their complementary 
sense probes were also assayed to avoid unspecific labeling. We observed an equal pattern of 
expression for the two antisense probes of each LGI gene we have used. In all cases, incubation 
with the sense probe did not produce any labeling in the tissue, demonstrating that the signal 
obtained for each probe is specific of each gene transcript, which was our main goal. The use of 
digoxigenin-labeled probes instead of the more sensitive radioactive probes, could lead us to an 
underestimation of the neurons expressing these genes, but in general this is a good approach for 
descriptive anatomy, which is the scope of the present study. In addition, digoxigenin-labeled 
probes provide a higher resolution in the observation of labeled areas, allowing us to discern within 
concrete brain areas. 
There are very few antibodies for the proteins encoded by these genes and when available, 
these antibodies did not work reliably in our hands, resulting in the absence of exhaustive 
immunohistochemical studies. Therefore, the importance of the mRNA expression of these genes 
becomes even more relevant. Besides, in situ hybridization minimizes usual problems that appear 
as a result of the use of antibodies, like weak signal or the lack of knockout mice for these genes 
to test specificity. 
To date the only comparative data on the distribution of LGI1-4 expressing cells was reported 
by Senechal et al. {Senechal, 2005 #5017}, in a study that focused on demonstrating that the LGI 
genes give rise to secreted protein products. In that study, the patterns of distribution for each LGI 
gene transcript were presented in a single sagital section for each gene, using digoxigenin-labeled 
probes. Their results for LGI1 and LGI2 expression were similar to ours, but here we show several 
differences that were seen for LGI3 and LGI4 transcripts. In addition, we observed some gene 
expression in additional areas, which were not considered in Senechal et al. study. 
The pattern of LGI1 expression in the hippocampus and cerebral cortex matches with the 
distribution reported in other studies using digoxigenin based ISH {Kalachikov, 2002 
#4318;Senechal, 2005 #5017}. In agreement with our findings, in these studies the highest LGI1 
signal was observed in the granular and pyramidal layers of the dentate gyrus and the CA3 field. 
Similarly to our results, some LGI1 expression was reported in the piriform cortex, amygdala and 
deep layers of the cerebral cortex. 
In addition, we observed clusters of LGI1 labeled perikarya in the superficial layers II and III of 
both medial and lateral entorhinal cortices. This observation is in agreement with the results 
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reported in a study using LGI1 immunocytochemistry, in which LGI1 labeling for the protein was 
found in the molecular layer of both dentate gyrus and Ammon’s horn {Schulte, 2006 #5039}. This 
molecular layer corresponds to the terminal field of the classical perforant pathway that arises from 
the superficial layers II and III of the entorhinal cortex {Witter, 1991 #5041}, suggesting that the 
LGI1 gene product is transported from the perikarya to the terminals. These data are consistent 
with the notion proposed by Schulte et al. that the LGI1 protein may be a subunit of the 
presynaptic voltage gated K+ channels {Schulte, 2006 #5039}. 
The caudal part of the dorsal division of the lateral septum (LSd) receives bilateral projections 
from the CA3 field and projects to the lateral supramammillary and the medial septum/diagonal 
band complex {Risold, 1997 #5042}. Then, the medial septum and lateral supramammillary 
nucleus project back to the hippocampal formation being, in part, responsible of theta 
synchronization {Kocsis, 1994 #5611}. In addition, electrical or chemical stimulation of the lateral 
supramammillary nucleus enhances granule cell synaptic excitability {Mizumori, 1989 
#5048;Carre, 1991 #5050;Nakanishi, 2001 #5049}. The majority of components of this loop 
express LGI1 transcripts and, in addition, a mutation of LGI1 protein produces an increase in 
cellular excitability through its association with presynaptic Kv1 channels when compared to wild-
type LGI1 {Schulte, 2006 #5039}. Taking together, these observations suggest that the 
connectivity among LGI1-expressing cell groups may be involved in the increased excitability that 
leads to the epileptic phenotype. In such conditions, theta-burst activity or other high-frequency 
excitations may trigger focal epileptic activity. 
Our results agree with those using ISH for LGI1 showing a restricted expression of LGI1 in the 
telencephalon {Kalachikov, 2002 #4318;Senechal, 2005 #5017}. However, LGI1 expression 
studies by Northern blot in mouse {Chernova, 1998 #3080} and by Western blot in human {Furlan, 
2006 #5615}, also showed expression of this gene in thalamus, cerebellum and spinal cord. These 
discrepancies could be due to the different sensitivity of the methods used in detecting LGI1 
expression. Besides, the expression of LGI1 in hippocampus and restricted cortical areas is in 
agreement with the development of lateral temporal epilepsies as it has been reported previously 
{Berkovic, 1991 #5616;Senechal, 2005 #5017} and also agrees with the fact that LGI1 protein 
mediates in the postnatal maturation of glutamatergic excitatory synapses in the hippocampus, 
which is arrested in transgenic LGI1-mutated mice {Zhou, 2009 #5614}. 
Senechal et al {Senechal, 2005 #5017} reported a specific LGI2 expression in the nucleus 
reticularis thalami and a diffuse pattern throughout the brain. These results are in agreement with 
the strong LGI2 signal we observed in the nucleus reticularis thalami. In addition, we were able to 
find other important locations where LGI2 labeling was robust and specific. Thus, we observed 
LGI2 labeled neurons in the hippocampus, pallidum, vertical limb of the diagonal band/medial 
septum, medial division of the lateral habenula, zona incerta and substantia nigra pars reticulata. 
The distribution of LGI2 genes in non principal neurons of the hippocampus, out of the pyramidal 
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and granular layers and in the vertical limb of the diagonal band allow us to speculate a 
possible role of LGI2 in theta rhythm synchronization. Most, if not all, non principal hippocampal 
neurons are GABA-ergic and contributes to hippocampal population oscillations (theta, gamma 
and 200 Hz ripples) (Freund and Buzsaki 1996). Also the medial septum contributes to 
synchronzation of the hippocampal neurons at theta frequency, in fact, the medial septum is 
considered to be the hippocampal theta pacemaker (Vertes and Kocsis 1999). The medial septum 
is composed of a heterogeneous population of glutamatergic, GABAergic and cholinergic neurons 
(Colom 9999, Sotty 2003) each one contributing in a different way to hippocampal synchronization 
(Sotty 2003). Besides, parvalbumin GABAergic neurons of the medial septum project to the 
hippocampal GABAergic non principal neurons {Freund, 1988 #5055;Freund, 1989 #5601}. The 
exact role of LGI2 in this system remains to be investigated.  
Our data show widespread expression of LGI3 in the diencephalon, whereas it is much lower in 
the rest of the brain. The fact that LGI3 is expressed in granular and pyramidal neurons of the 
hippocampal formation might indicate a possible relation of the expression of this gene with 
excitatory aminoacid neurons. Although the widespread distribution of the LGI3 transcripts does 
not allow postulating a particular function, the fact that the strongest activity was found in 
hippocampal cells suggests that this might be considered as a good system for studying 
LGI3-Abeta interactions in glia and pyramidal cells.  
Our data show that the regional distribution of LGI4 transcripts is similar to that observed for 
LGI2. Indeed, we found LGI4 labeled cells in both the nucleus reticularis thalami and medial 
septum, similar to the distribution of LGI2 transcripts. Nevertheless, some differences were 
observed in the patterns of expression of both genes, suggesting possible different roles for LGI2 
and LGI4 products. In addition to the labeling observed in putative interneurons, LGI4 signal was 
also weakly, but consistently, expressed in the granular and pyramidal layers of the hippocampus, 
whereas LGI2 signal was absent. LGI2 was highly expressed in the lateral globus pallidus 
whereas LGI4 expression was weak. LGI2 expression was present in the medial division of the 
medial mammillary nucleus, which was devoid of LGI4 signal. In contrast, LGI4 labeling was 
stronger than LGI2 labeling in the ventral tegmental area. Our pattern of LGI4 expression differs 
somewhat from that reported by Senechal et al. {Senechal, 2005 #5017}, who showed some LGI4 
signal in the rostral migratory stream leading to the olfactory bulb. In our study, we used one probe 
located in the 3’-end of the cDNA and a second probe in the coding region of the LGI4 gene, and 
both probes provided the same pattern of labeling.  
The LGI4 gene product has been proposed to play a role in peripheral nerve development. 
Bermingham et al. demonstrated LGI4 expression in Schwann cells, and found that defective 
forms of the LGI4 gene result in the claw paw mutation {Bermingham, 2006 #5032}, characterized 
by axonal shorting and hypomyelination throughout the peripheral nervous system in mice. In 
addition, the authors also discovered that silencing the LGI4 gene in Schwann cell cultures inhibits 
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myelination, which is restored by applying exogenous LGI4 protein product {Bermingham, 2006 
#5032}. 
In summary, we have found that LGI genes can be classified into three main groups of LGI 
genes: LGI1, LGI2/4 and LGI3. LGI1 gene products might be involved in the presynaptic regulation 
of voltage-gated K+ channels through several pathways. One is the classical trisynaptic pathway 
that originates in the entorhinal cortex and ends in the CA1 field; the second is a longer pathway, 
which emerges from the CA3 field towards the caudal dorsal lateral septum, and from there, 
towards the lateral supramammillary nucleus. This projects backwards to the dentate gyrus and 
the CA3 field in a projection that did not contain LGI1 regulation. The role of LGI1 along the 
pathway remains to be determined. Defective forms of the LGI1 protein might maintain 
depolarization throughout these pathways leading to ADLTE. The pattern of expression of LGI2 
and LGI4 genes coincides in the medial septum and nucleus reticularis thalami, (and seems to be 
associated with GABAergic neurons) although regional differences were also found. Finally, the 
widespread expression of LGI3 gene in numerous brain areas suggests that the product of this 
gene could be involved in a common cellular process in different neuronal types. The non-
restricted pattern of expression of this gene precludes proposing a particular function for its 
products. 
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4. EXPERIMENTAL PROCEDURE 
Animals: 
Adult C57BL/6J male mice (n=20; weight=25-35 gr) from Harlan, were maintained at a 
12:12 hours light/dark cycle at 22 ºC, with ad libitum access to food and water. All experiments 
were carried out conformed to the guidelines for animal experimentation on the ethical use of 
animals of the CSIC and the School of Medicine of the University of Valencia. All efforts were 
made to minimize the number of animals used and their suffering. 
 
Design and synthesis of probes: 
We designed two probes for each LGI gene mRNA (LGI1-4). Homology searches using NCBI-
BLAST were performed to ensure that each probe had no homology with any other sequence in 
the public databases. Special caution was taken in the case of LGI4, given that its 3’-UTR overlaps 
with the 3’-UTR region of the Fxyd3 gene, encoded in the reverse strand. Such region was 
avoided in order to guarantee the specifity of our probes. 
The selected probes were the complementary sequences to the following mouse mRNA 
genome regions: Nucleotides 379 to 909 corresponding to exons 3 to 7 (probe 1) and nucleotides 
1659 to 2174 within exon 8 and the 3’ untranslated region (3’-UTR; probe 2) for LGI1 (GenBank 
accession no. NM_020278); nucleotides 1700 to 2343 from the 3’-UTR (probe 1) and nucleotides 
482 to 1019 within exons 3 and 6 (probe 2) for LGI2 (GenBank accession no. NM_144945); 
nucleotides 280 to 823 within exons 1 and 6 (probe 1) and nucleotides 1790 to 2344 in the 3’-UTR 
(probe 2) for LGI3 (GenBank accession number: NM_145219); nucleotides 538 to 1091 
corresponding to exons 5 and 8 (probe 1) and nucleotides 1707 to 2252 in the 3’-UTR (probe 2) 
for LGI4 (GenBank accession no. NM_144556). All the sequences mentioned above were 
PCR-amplified from a mouse cDNA library (Invitrogen). Primers used at this stage, along with the 
size of the corresponding probe, are shown in Table 1. The amplification conditions were as 
follows: 5 minutes of initial denaturalization at 94 ºC, 30 cycles of 30 seconds at 94 ºC, 30 seconds 
at 58 ºC and 1 minute at 72 ºC, followed by a final extension of 10 minutes at 72 ºC. Pfu turbo 
polymerase from Stratagene was used for these amplifications following the manufacturer's 
indications. The PCR product was resoluted in 1% agarose gel in tris-borate-EDTA buffer (TBE, 
89 mM tris, 89 mM boric acid, 20 mM EDTA, pH 8). The band corresponding to the expected 
fragment size was isolated and purified using a Minelute gel extraction kit (Qiagen). Subsequently, 
the fragment was digested with Sal I and Xho I for the LGI1 probes, and with EcoR I and Xho I for 
the remaining probes (all restriction enzymes were purchased from Fermentas. The resulting 
sequences were cloned into pBluescript KS II (-) (Stratagene) with a Rapid ligation kit (Roche) and 
transformed into DH5- electrocompetent bacteria. These constructs were subsequently 
sequenced to verify their integrity. 
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Once cloned, the constructs were amplified in bacteria. Following phenol purification, an in 
vitro synthesis of the RNA probes with digoxigenin-labeled nucleotides was performed using an 
RNA oligonucleotide synthesis kit (Roche), following the manufacturer’s instructions. The integrity 
of the probes was verified by resoluting them in 1% agarose gel in TBE buffer, and the products 
were stored with 50% formamide to prevent the formation of secondary structures. 
 
In situ hybridization: 
To avoid the activity of ribonucleases, all material was washed with ethanol and heated for at 
least two hours at 200 ºC prior to in situ hybridization. In addition, all solutions were treated with 
1:104 diethyl-pyrocarbonate (DEPC, Sigma-Aldrich) and autoclaved. All steps were performed at 
4 ºC if not otherwise specified. 
Animals were killed by subcervical dislocation and the brains were quickly removed, washed in 
0.1 M phosphate buffered saline (PBS; 137 mM NaCl; 2.68 mM KCl; 6.48 mM Na2HPO4; 
647 mM KH2PO4) and fixed overnight in 4% paraformaldehyde in PBS. Brains were then washed 
for 30 minutes in PBS and embedded in gelatin. Then, 50 µm sections were obtained with a Leica 
vibratome and stored in 4% paraformaldehyde until further use. For each brain four parallel 
subseries were obtained and reacted with the correlative set of LGI1-4 probes (two sense and 
antisense probes were used for each gene). To remove the residual paraformaldehyde, free-
floating sections were washed twice with PBST (0.1% Tween 20 in PBS) followed by gradual 
dehydration with 25%, 50%, 75%, and 100% methanol in PBST and vice versa. Next, sections 
were washed with PBST and incubated with 1% H2O2 in PBST for 10 minutes. Afterwards, 
sections were washed again with PBST, treated with 5 µg/ml of proteinase K for 7 minutes at room 
temperature and postfixed with 4% paraformaldehyde for 20 minutes. Sections were then washed 
again before a prehybridization step of at least 2 hours with hybridization solution (50% deionized 
formamide; 5X SSC; 2% blocking powder (Roche), 0,1% Triton X-100; 1 mg/ml yeast tRNA; 
5 mM EDTA; 50 µg/ml heparin) at 57 ºC. Next, fresh solution was added, followed by the addition 
of the digoxigenin labeled RNA probes at a final concentration of 1 µg/ml. The probes were left to 
hybridize overnight at 57 ºC. The next day, 5 high stringency washes were carried out for 
30 minutes each with 0.1% CHAPS (Sigma, 3-[(3-cholamidopropyl) dimethylammonio]-1-
propanesulfonate), 2X SSC in DEPC treated H2O at 57 ºC. After blocking with 20% fetal calf 
serum in KTBT (50 mM Tris-HCl pH 7.5; 150 mM NaCl; 10 mM KCl; 0.3% Triton X-100) for 
3 hours, sections were incubated with 1:1000 sheep anti-digoxigenin alkaline phosphatase-
conjugated antibody (anti-DIG-AP) (Roche) in blocking solution overnight. To prevent unspecific 
reactivity of the antibody, we pre-absorbed the anti-DIG-AP antibody with brain powder. Brain 
powder was obtained by homogenizing several mouse brains in a minimal volume of PBS. 
Following centrifugation of the brain homogenate at 3000 g for 30 minutes, the pellet was washed 
with ice-cold acetone, dried, and crushed to obtain a fine powder. The next day we carried out 
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5 one-hour washes of the sections with KTBT at room temperature. An alkaline phosphatase-
mediated color reaction was obtained by incubating the sections in 333 mg/ml of 4-nitroblue 
tetrazolium chloride (Roche) and 165 mg/ml of 5-bromo-4-chloro-3-indolyl phosphate (Roche) in 
NTMT buffer (100 mM Tris-HCl pH 9.5; 50 mM MgCl; 100 mM NaCl; 0.1% Tween-20) to obtain a 
blue-purple precipitate. When the desired level of color reaction was observed (after 2-3 hours 
incubation), sections were gently washed in KTBT overnight, followed by a final wash with PBS 
prior to mounting the sections on superfrost/plus slides (Microm). Slides were dried overnight and 
were coverslipped next day with Eukitt (Zeiss). 
Parallel control experiments were carried out for all the probes using the sense sequence of the 
probe, always at the same concentration as the respective antisense probe, to assess possible 
non-specific hybridization. 
 
Analysis of the anatomical distribution of LGI transcripts: 
Each section series reacted with a LGI probe was analyzed with a Nikon Eclipse E600 
microscope at 4x, 10x and 20x objectives in bright field illumination. Each section was compared 
with the corresponding level of the Paxinos and Franklin mouse brain atlas {Paxinos, 2001 #5612}, 
from which we obtained a set of diagrams for the representation of the expression of the genes. 
Our set of diagrams (Figure 1) starts at Bregma level +3.08 mm (A1-A4) and finishes at level -
7.64 mm (S1-S4). Consecutive diagrams are separated 0.5 mm. Dots represent labeling in the 
represented area under our subjective criteria for quantification. Additionally, expression levels 
were also registered for the most representative areas. Quantification was estimated under our 
subjective criteria (Table 2). 
Some representative pictures showing the distribution of the labeled transcripts for the four LGI 
genes were obtained in brightfield, using a Nikon DMX-1200 camera connected to a computer. 
The images were captured using software ACT1 (Nikon). The images were only adjusted for 
brightness and contrast using Adobe Photoshop. 
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TABLE AND FIGURE LEGENDS 
Table 1.- Primers and restriction sites used for cloning the different probes designed for in situ 
hybridization. 
 
Table 2.- Relative levels of expression for each LGI gene estimated by visual comparison in 
representative areas of the mouse central nervous system. 
 
Figure 1.-  Diagrams showing the distribution and relative strength of the ISH signal for each LGI 
gene (LGI1-4) across the mouse brain. Diagrams were obtained by modifying templates from the 
Paxinos and Franklin’s mouse atlas (2001). The diagrams start at Bregma level +3.08 mm (A1-A4) 
and finish at level -7.64 mm (S1-S4). Consecutive diagrams are separated 0.5 mm.  The strong 
similarity between LGI2 (right side, first column) and LGI4 (right side, second column) expression 
is apparent. All scale bars are 1 mm. 
 
Figure 2.-  Photomicrographs showing the expression of LGI1 gene in several brain regions. A) 
Absence of LGI1 labeling after incubation with the sense probe. B) LGI1 signal obtained with the 
antisense probe 1, which is strong in the dentate gyrus (DG) and CA3, and low in fasciola cinerea 
(FC) and in CA1. C) LGI1 labeling in the dentate gyrus and in some scattered cells in the dorsal 
subiculum (DSub) of the posterior hippocampus is shown at higher magnification. Similarly, a 
detail of the entorhinal cortex (Ent), illustrating the weak but consistent labeling in the superficial 
layer, is shown in D). LGI1 signal in the anterior basolateral (BLA) and central (CeA) nuclei of the 
amygdala can be appreciated in E). In F) low LGI1 signal was also observed in the dorsal lateral 
septal nucleus (LSd) and in putamen (Pu). Scale bars in A and B = 500 µm; rest of 
images = 200 µm. 
 
Figure 3.-  Photomicrographs showing the expression of LGI2 gene A) Dispersed labeled cells 
were observed in all layers of the olfactory bulb (arrows). B) Intense LGI2 labeling of the majority 
of neurons of the external division of the anterior olfactory nuclei (AOE) along the olfactory 
peduncle. C) Illustrates the labeling in the parietal cortex, mainly in the deep layers, as it occurs in 
the rest of the cerebral cortex. D) LGI2 labeling in the piriform cortex (Pir) was strong in layer II 
and diffuse in layer III. E) Shows dispersed labeled cells in both the Ammon’s horn and dentate 
gyrus, whereas pyramidal and granular layers remain unlabeled. LGI2 labeling is also shown in 
the lateral habenular nucleus (lHb) whereas, in contrast, is absent in the medial habenular nucleus 
(mHb). F) LGI2 labeling in the thalamus and basal ganglia; strong signal was observed in the 
reticular thalamic nucleus (Rt), with some labeling also apparent in the lateral pallidal nucleus 
(Pa). Scattered labeled cells were also seen in the putamen (Pu) and in several amygdalar nuclei 
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such as the lateral (LA), central (CeA) or medial amygdala (MeA). G) LGI2 signal in the medial 
septum and diagonal band nuclei; strong labeling was observed in the vertical limb of the diagonal 
band, although some scattered labeled cells were also detected in the transition between medial 
and lateral septum (MS/LS). LGI2 labeling was absent in the horizontal limb (hDB). Scale bars in E 
and F = 500 µm; rest of images = 200 µm. 
 
Figure 4.- Photomicrographs showing some details of LGI2 expression.  A) LGI2 labeling was 
found in the zona incerta (ZI), ventral to the mammillothalamic tract (mta). B) In the mammillary 
bodies, LGI2 was specifically and strongly expressed in the median division of the medial 
mammillary nucleus. C) In the caudal medulla, strong LGI2 labeling was observed in the large 
neurons of the inferior olivary complex. Some labeled neurons were also apaprent in the medullary 
reticular formation (RF). D) In the cerebellum, a strong LGI2 signal was observed in some 
regularly dispersed neurons of the granular layer of the cerebellar laminae. In addition, LGI2 
expression was also found in neurons of the deep cerebellar nuclei, such as the dentate nucleus. 
Scale bars in C and D = 100 µm; rest of images = 200 µm. 
 
Figure 5.- Photomicrographs showing the expression of LGI3 gene. A) There was strong LGI3 
expression in the granular and pyramidal neurons of the dentate gyrus and Ammons’s horn. In 
addition, some disperse neurons, most likely interneurons, were observed in the rest of layers. 
B) The LGI3 labeling in the amygdalar complex was strong in the lateral nucleus and in the medial 
division of the central nucleus. C) Widespread and weak LGI3 expression in the laterodorsal 
thalamic nucleus. D) LGI3 labeling in the medial habenula (mHb) contrasts with the lack of signal 
in the lateral habenula (lHb). In addition, some weak LGI3 labeling was seen in the posterior 
paraventricular thalamic nucleus (PVP). E) Some labeling was also apparent in the substantia 
nigra (SN), ventral tegmental area (VTA) and interpeduncular nucleus (IP). F) LGI3 signal was 
also present in the median raphe (MnR). Scale bar in C = 100 µm; the rest of images = 200 µm. 
 
Figure 6.- Photomicrographs showing the expression of LGI4 gene in some brain regions. Note 
that the pattern of labeling is similar to that of LGI2 transcripts. A) In the parietal cortex, LGI4 
labeling was mainly observed in the deep layers. B) LGI4 signal in the hippocampus was found in 
dispersed cells, but was also present in the granular and pyramidal layers, and in the reticular 
nucleus. C) LGI4 labeling was found in the vertical limb of the diagonal band of the medial septum 
(MS). D) Strong labeling was present in the supracapsular division of the bed nucleus of the stria 
terminalis (BST). In contrast, scattered labeled cells were observed in the ventral pallidum (VP). 
LGI4 expression was almost absent in nearly all hypothalamic nuclei, including the medial preoptic 
nucleus (MPO). E) Some LGI4 labeling was evident in the putamen and in the lateral pallidum. F) 
A group of LGI4 labeled cells was specifically located in the deep dorsal nucleus (DD) of the 
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posterior intralaminar complex (PIN), between the dorsal and ventral divisions of the medial 
geniculate body (MGd and MGv, respectively). Scale bars in B and D = 500 µm; rest of 
images = 200 µm. 
 
Figure 7.- Photomicrographs showing some details of LGI4 expression in the mesencephalon. 
A) A strong LGI4 labeling is clearly seen in the pars compacta of the substantia nigra (SNc) and 
the ventral tegmental area (VTA). Scattered labeled cells were present in the deep mesencephalic 
reticular formation (DeMe) and the pars reticulata of the substantia nigra (SNr). LGI4 labeling was 
absent in the supramammillary (SuM) nucleus and in all mammillary nuclei (mMM, lMM, LM). 
B) High magnification of the LGI4 labeling observed in the substantia nigra in photomicrograph B. 
C) In the caudal mesencephalon, the LGI4 labeling was observed in the interpeduncular nucleus 
(IP) and in the interfascicular nucleus (IF). Scale bar in A = 500 µm; rest of images = 200 µm. 
